De novo calcineurin inhibitor free immunosuppression after cardiac transplantation is possible!

Objectives: The aim of this prospective pilot study was to investigate, for the first time since the introduction of cyclosporine, whether de novo calcineurin inhibitor free immunosuppression after HTx is efficacious and can prevent calcineurin inhibitor specific adverse effects.